副腎がん診断薬の世界市場レポート 2025年

副腎がん診断薬市場規模は、今後数年間で力強い成長が見込まれます。2029年にはCAGR6.5％で1,932億6,000万米ドルに成長します。予測期間の成長は、個別化医療へのアプローチ、低侵襲手術の増加、遠隔医療と遠隔診察、リキッドバイオプシーの開発、遺伝カウンセリングサービスの拡大などに起因すると考えられます。予測期間の主な動向には、診断イノベーションに対する規制支援、デジタルパソロジーの採用、画像技術の進歩、リキッドバイオプシーの開発、精密医療のためのゲノムプロファイリングなどが含まれます。

たばこ喫煙の増加が予想され、副腎がん診断薬市場の成長を牽引します。タバコの喫煙は、精神作用のある中毒性のアルカロイドであるニコチンを含むタバコの燃焼ガスを吸ったり吐いたりしています。副腎腺腫や副腎皮質がんを含む副腎がんは、タバコの喫煙に関連するリスクの増加と関連しています。タバコの煙に含まれる発がん物質が副腎細胞のDNA損傷を引き起こし、がんの原因となる突然変異を引き起こす可能性があります。注目すべきは、カナダ統計局の報告によると、2022年7月のたばこ生産量は2021年6月と比べて5.8％増加し、2022年6月の総販売本数は14億本に達したことです。このように、タバコの喫煙率の増加は副腎がん診断薬市場の主要な促進要因となっています。

がんを支援する政府のイニシアチブは、副腎がん診断薬市場の成長を促進すると予想されます。これらのイニシアチブには、課題への対処、診断サービスの質とアクセシビリティの向上、効果的な副腎がん診断薬のための調査支援など、政府による重要な行動が含まれます。2023年4月、Biden-Harris政権はNational Institutes of Health（NIH）に従い、がんに耐え、がんを克服した個人への支援を強化する一方で、25年以内にがん関連死亡を50％減少させるイニシアチブを確立しました。政府のイニシアチブは、副腎がん診断薬市場の成長促進に大きく貢献しています。

目次

第1章 エグゼクティブサマリー

第2章 市場の特徴

第3章 市場動向と戦略

第4章 市場- 金利、インフレ、地政学、コロナ、回復が市場に与える影響を含むマクロ経済シナリオ

第5章 世界の成長分析と戦略分析フレームワーク

• 世界副腎がん診断薬PESTEL分析（政治、社会、技術、環境、法的要因、促進要因、抑制要因）
• 最終用途産業の分析
• 世界の副腎がん診断薬市場：成長率分析
• 世界の副腎がん診断薬市場の実績：規模と成長, 2019-2024
• 世界の副腎がん診断薬市場の予測：規模と成長, 2024-2029, 2034F
• 世界副腎がん診断薬総アドレス可能市場（TAM）

第6章 市場セグメンテーション

• 世界の副腎がん診断薬市場テストによる、実績と予測, 2019-2024, 2024-2029F, 2034F
• 磁気共鳴画像（MRI）
• コンピュータ断層撮影（CT）スキャン
• X線
• 陽電子放出断層撮影（PET）スキャン
• 生検
• 世界の副腎がん診断薬市場治療別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 手術
• 化学療法
• 放射線治療
• 標的がん治療
• その他の治療法
• 世界の副腎がん診断薬市場腫瘍の種類別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 褐色細胞腫
• 副腎皮質がん
• その他のタイプ
• 世界の副腎がん診断薬市場：エンドユーザー別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 病院
• 外来手術センター
• がんセンター
• その他のエンドユーザー
• 世界の副腎がん診断薬市場磁気共鳴画像（MRI）のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造影MRI
• 機能的MRI
• 世界の副腎がん診断薬市場、コンピュータ断層撮影（CT）スキャンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 造影CT
• 腹部および骨盤CTスキャン
• 世界の副腎がん診断薬市場、X線の種類別のサブセグメンテーション、実績と予測, 2019-2024, 2024-2029F, 2034F
• 標準X線画像
• 特殊なX線技術
• 世界の副腎がん診断薬市場、陽電子放出断層撮影（PET）スキャンのサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• PET-CT複合スキャン
• スタンドアロンPETスキャン
• 世界の副腎がん診断薬市場、生検のサブセグメンテーション、タイプ別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 穿刺吸引細胞診（FNA）
• コア針生検
• 外科的生検

第7章 地域別・国別分析

• 世界の副腎がん診断薬市場：地域別、実績と予測, 2019-2024, 2024-2029F, 2034F
• 世界の副腎がん診断薬市場：国別、実績と予測, 2019-2024, 2024-2029F, 2034F

第8章 アジア太平洋市場

第9章 中国市場

第10章 インド市場

第11章 日本市場

第12章 オーストラリア市場

第13章 インドネシア市場

第14章 韓国市場

第15章 西欧市場

第16章 英国市場

第17章 ドイツ市場

第18章 フランス市場

第19章 イタリア市場

第20章 スペイン市場

第21章 東欧市場

第22章 ロシア市場

第23章 北米市場

第24章 米国市場

第25章 カナダ市場

第26章 南米市場

第27章 ブラジル市場

第28章 中東市場

第29章 アフリカ市場

第30章 競合情勢と企業プロファイル

• 副腎がん診断薬市場：競合情勢
• 副腎がん診断薬市場：企業プロファイル
  • Johnson And Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

第31章 その他の大手企業と革新的企業

• Abbott Laboratories
• Siemens Healthcare GmbH
• Becton Dickinson and Company
• Koninklijke Philips N.V.
• GE HealthCare Technologies Inc.
• Agilent Technologies
• Hologic Inc.
• PerkinElmer Inc.
• Illumina Inc.
• Roche Diagnostics
• BioMerieux SA
• Sysmex Corporation
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Exact Sciences Corp.

第32章 世界の市場競合ベンチマーキングとダッシュボード

第33章 主要な合併と買収

第34章 最近の市場動向

第35章 市場の潜在力が高い国、セグメント、戦略

• 副腎がん診断薬市場2029：新たな機会を提供する国
• 副腎がん診断薬市場2029：新たな機会を提供するセグメント
• 副腎がん診断薬市場2029：成長戦略
  • 市場動向に基づく戦略
  • 競合の戦略

第36章 付録

Adrenal cancer diagnostics involve the identification and detection of cancer originating in the adrenal glands, situated above the kidneys. This process encompasses a series of medical assessments, tests, and procedures designed to establish the presence of adrenal cancer, playing a crucial role in effective treatment planning and management.

The primary diagnostic tests for adrenal cancer include magnetic resonance imaging (MRI), computed tomography (CT) scans, X-rays, positron emission tomography (PET) scans, and biopsies. Magnetic resonance imaging (MRI) is a medical imaging technique that utilizes strong magnetic fields and radio waves to generate detailed and high-resolution images of the body's internal structures. Treatment modalities encompass surgery, chemotherapy, radiotherapy, targeted cancer therapies, and others tailored for pheochromocytoma, adrenal cortical carcinoma, and various tumor types. These treatments are administered by diverse end-users such as hospitals, ambulatory surgical centers, cancer centers, and others.

The adrenal cancer diagnostics market research report is one of a series of new reports from The Business Research Company that provides adrenal cancer diagnostics market statistics, including adrenal cancer diagnostics industry global market size, regional shares, competitors with an adrenal cancer diagnostics market share, detailed adrenal cancer diagnostics market segments, market trends and opportunities, and any further data you may need to thrive in the adrenal cancer diagnostics industry. This adrenal cancer diagnostics market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The adrenal cancer diagnostics market size has grown strongly in recent years. It will grow from $140.35 billion in 2024 to $149.96 billion in 2025 at a compound annual growth rate (CAGR) of 6.8%. The growth in the historic period can be attributed to increased incidence and awareness, genetic and molecular testing advances, biopsy techniques improvement, enhanced endocrine testing, integration of artificial intelligence (ai).

The adrenal cancer diagnostics market size is expected to see strong growth in the next few years. It will grow to $193.26 billion in 2029 at a compound annual growth rate (CAGR) of 6.5%. The growth in the forecast period can be attributed to personalized medicine approaches, rise in minimally invasive procedures, telemedicine and remote consultations, liquid biopsy development, expanded genetic counseling services. Major trends in the forecast period include regulatory support for diagnostic innovations, digital pathology adoption, advancements in imaging technologies, liquid biopsy development, genomic profiling for precision medicine.

The anticipated rise in cigarette smoking is poised to drive the growth of the adrenal cancer diagnostics market. Cigarette smoking involves inhaling and exhaling fumes from burning tobacco containing nicotine, an addictive alkaloid with psychoactive effects. Adrenal cancer, including adenomas and adrenocortical carcinomas, has been linked to increased risks associated with cigarette smoking. The carcinogens in tobacco smoke can lead to DNA damage in adrenal cells, resulting in mutations that may cause cancer. Notably, Statistics Canada reported a 5.8% increase in cigarette production in July 2022 compared to June 2021, with the total number of cigarettes sold reaching 1.4 billion in June 2022. Thus, the growing prevalence of cigarette smoking is a key driver for the adrenal cancer diagnostics market.

Government initiatives supporting cancer are expected to propel the growth of the adrenal cancer diagnostics market. These initiatives involve significant actions taken by governments to address challenges, improve diagnostic services' quality and accessibility, and support research for effective adrenal cancer diagnostics. In April 2023, the Biden-Harris administration, as per the National Institutes of Health (NIH), established an initiative to reduce cancer-related deaths by 50% within 25 years while enhancing support for individuals enduring and surviving cancer. Government initiatives contribute significantly to driving the growth of the adrenal cancer diagnostics market.

Leading companies in the adrenal cancer diagnostics market are launching innovative initiatives through advanced collaboration models, such as the CancerX Startup Accelerator, to boost digital innovations in cancer care. This Accelerator is designed to offer promising startups mentorship, training, and direct connections to key stakeholders in the healthcare sector, including providers and pharmaceutical firms. For instance, in November 2023, CanceRx, LLC, a US-based public-private partnership aimed at enhancing innovation in the fight against cancer, announced the launch of this initiative during the Future of Cancer Care Summit held in Tampa, Florida. The program plans to select its first cohort of about 15 to 20 companies starting in March 2024, concentrating on critical themes such as clinical research, screening, diagnosis, and treatment. It is anticipated that this initiative will significantly advance the objectives of the Cancer Moonshot initiative by tackling unmet needs in cancer care and promoting the development of effective digital health tools in oncology.

In June 2023, Quest Diagnostics, a US-based medical laboratory company, acquired Haystack Oncology, Inc. for an undisclosed sum. As a result of this acquisition, Quest Diagnostics will integrate Haystack Oncology's minimal residual disease (MRD) testing technology, which is based on circulating tumor DNA (ctDNA). Haystack Oncology, Inc. is a biotechnology company located in the United States.

Major companies operating in the adrenal cancer diagnostics market report are Johnson And Johnson Pvt Ltd., F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific, GSK PLC, AstraZeneca PLC, Abbott Laboratories, Siemens Healthcare GmbH, Becton Dickinson and Company, Koninklijke Philips N.V., GE HealthCare Technologies Inc., Agilent Technologies, Hologic Inc., PerkinElmer Inc., Illumina Inc., Roche Diagnostics, BioMerieux SA, Sysmex Corporation, Bio-Rad Laboratories Inc., Bruker Corporation, Exact Sciences Corp., Natera Inc., Invitae Corporation, Qiagen NV, Guardant Health Inc., Foundation Medicine Inc., NanoString Technologies Inc., TRS Technologies Inc., Morgan Advanced Materials, APC International Ltd., Annon Piezo Technology Co. Limited

North America was the largest region in the adrenal cancer diagnostics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the adrenal cancer diagnostics market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The adrenal cancer diagnostics market consists of revenues earned by entities by providing genetic testing, histopathology, blood tests, and dexamethasone suppression tests. The market value includes the value of related goods sold by the service provider or included within the service offering. The adrenal cancer diagnostics market also includes sales of ultrasound machines, reagents and test kits, microscopes, histology kits, and microtomes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Adrenal Cancer Diagnostics Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on adrenal cancer diagnostics market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for adrenal cancer diagnostics ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The adrenal cancer diagnostics market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Test: Magnetic Resonance Imaging (MRI); Computed Tomography (CT) Scan; X-ray; Positron Emission Tomography (PET) Scan; Biopsy
• 2) By Treatment: Surgery; Chemotherapy; Radiotherapy; Targeted Cancer Therapies; Other Treatments
• 3) By Tumor Type: Pheochromocytoma; Adrenal Cortical Carcinoma; Other Types
• 4) By End-User: Hospitals; Ambulatory Surgical Centers; Cancer Centers; Other End-Users
• Subsegments:
• 1) By Magnetic Resonance Imaging (MRI): Contrast-Enhanced MRI; Functional MRI
• 2) By Computed Tomography (CT) Scan: Contrast-Enhanced CT; Abdomen And Pelvis CT Scans
• 3) By X-ray: Standard X-ray Imaging; Specialized X-ray Techniques
• 4) By Positron Emission Tomography (PET) Scan: PET-CT Combination Scans; Standalone PET Scans
• 5) By Biopsy: Fine Needle Aspiration Biopsy (FNA); Core Needle Biopsy; Surgical Biopsy
• Companies Mentioned: Johnson And Johnson Pvt Ltd.; F. Hoffmann-La Roche Ltd.; Thermo Fisher Scientific; GSK plc; AstraZeneca plc
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Adrenal Cancer Diagnostics Market Characteristics

3. Adrenal Cancer Diagnostics Market Trends And Strategies

4. Adrenal Cancer Diagnostics Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Covid And Recovery On The Market

5. Global Adrenal Cancer Diagnostics Growth Analysis And Strategic Analysis Framework

• 5.1. Global Adrenal Cancer Diagnostics PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Adrenal Cancer Diagnostics Market Growth Rate Analysis
• 5.4. Global Adrenal Cancer Diagnostics Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Adrenal Cancer Diagnostics Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Adrenal Cancer Diagnostics Total Addressable Market (TAM)

6. Adrenal Cancer Diagnostics Market Segmentation

• 6.1. Global Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Magnetic Resonance Imaging (MRI)
• Computed Tomography (CT) Scan
• X-ray
• Positron Emission Tomography (PET) Scan
• Biopsy
• 6.2. Global Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Surgery
• Chemotherapy
• Radiotherapy
• Targeted Cancer Therapies
• Other Treatments
• 6.3. Global Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pheochromocytoma
• Adrenal Cortical Carcinoma
• Other Types
• 6.4. Global Adrenal Cancer Diagnostics Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Hospitals
• Ambulatory Surgical Centers
• Cancer Centers
• Other End-Users
• 6.5. Global Adrenal Cancer Diagnostics Market, Sub-Segmentation Of Magnetic Resonance Imaging (MRI), By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contrast-Enhanced MRI
• Functional MRI
• 6.6. Global Adrenal Cancer Diagnostics Market, Sub-Segmentation Of Computed Tomography (CT) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Contrast-Enhanced CT
• Abdomen And Pelvis CT Scans
• 6.7. Global Adrenal Cancer Diagnostics Market, Sub-Segmentation Of X-ray, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Standard X-ray Imaging
• Specialized X-ray Techniques
• 6.8. Global Adrenal Cancer Diagnostics Market, Sub-Segmentation Of Positron Emission Tomography (PET) Scan, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• PET-CT Combination Scans
• Standalone PET Scans
• 6.9. Global Adrenal Cancer Diagnostics Market, Sub-Segmentation Of Biopsy, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Fine Needle Aspiration Biopsy (FNA)
• Core Needle Biopsy
• Surgical Biopsy

7. Adrenal Cancer Diagnostics Market Regional And Country Analysis

• 7.1. Global Adrenal Cancer Diagnostics Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Adrenal Cancer Diagnostics Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Adrenal Cancer Diagnostics Market

• 8.1. Asia-Pacific Adrenal Cancer Diagnostics Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Adrenal Cancer Diagnostics Market

• 9.1. China Adrenal Cancer Diagnostics Market Overview
• 9.2. China Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Adrenal Cancer Diagnostics Market

• 10.1. India Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Adrenal Cancer Diagnostics Market

• 11.1. Japan Adrenal Cancer Diagnostics Market Overview
• 11.2. Japan Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Adrenal Cancer Diagnostics Market

• 12.1. Australia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Adrenal Cancer Diagnostics Market

• 13.1. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Adrenal Cancer Diagnostics Market

• 14.1. South Korea Adrenal Cancer Diagnostics Market Overview
• 14.2. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Adrenal Cancer Diagnostics Market

• 15.1. Western Europe Adrenal Cancer Diagnostics Market Overview
• 15.2. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Adrenal Cancer Diagnostics Market

• 16.1. UK Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Adrenal Cancer Diagnostics Market

• 17.1. Germany Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Adrenal Cancer Diagnostics Market

• 18.1. France Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Adrenal Cancer Diagnostics Market

• 19.1. Italy Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Adrenal Cancer Diagnostics Market

• 20.1. Spain Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Adrenal Cancer Diagnostics Market

• 21.1. Eastern Europe Adrenal Cancer Diagnostics Market Overview
• 21.2. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Adrenal Cancer Diagnostics Market

• 22.1. Russia Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Adrenal Cancer Diagnostics Market

• 23.1. North America Adrenal Cancer Diagnostics Market Overview
• 23.2. North America Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Adrenal Cancer Diagnostics Market

• 24.1. USA Adrenal Cancer Diagnostics Market Overview
• 24.2. USA Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Adrenal Cancer Diagnostics Market

• 25.1. Canada Adrenal Cancer Diagnostics Market Overview
• 25.2. Canada Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Adrenal Cancer Diagnostics Market

• 26.1. South America Adrenal Cancer Diagnostics Market Overview
• 26.2. South America Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Adrenal Cancer Diagnostics Market

• 27.1. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Adrenal Cancer Diagnostics Market

• 28.1. Middle East Adrenal Cancer Diagnostics Market Overview
• 28.2. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Adrenal Cancer Diagnostics Market

• 29.1. Africa Adrenal Cancer Diagnostics Market Overview
• 29.2. Africa Adrenal Cancer Diagnostics Market, Segmentation By Test, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Adrenal Cancer Diagnostics Market, Segmentation By Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Adrenal Cancer Diagnostics Market, Segmentation By Tumor Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Adrenal Cancer Diagnostics Market Competitive Landscape And Company Profiles

• 30.1. Adrenal Cancer Diagnostics Market Competitive Landscape
• 30.2. Adrenal Cancer Diagnostics Market Company Profiles
  • 30.2.1. Johnson And Johnson Pvt Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. F. Hoffmann-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Thermo Fisher Scientific Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. GSK plc Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. AstraZeneca plc Overview, Products and Services, Strategy and Financial Analysis

31. Adrenal Cancer Diagnostics Market Other Major And Innovative Companies

• 31.1. Abbott Laboratories
• 31.2. Siemens Healthcare GmbH
• 31.3. Becton Dickinson and Company
• 31.4. Koninklijke Philips N.V.
• 31.5. GE HealthCare Technologies Inc.
• 31.6. Agilent Technologies
• 31.7. Hologic Inc.
• 31.8. PerkinElmer Inc.
• 31.9. Illumina Inc.
• 31.10. Roche Diagnostics
• 31.11. BioMerieux SA
• 31.12. Sysmex Corporation
• 31.13. Bio-Rad Laboratories Inc.
• 31.14. Bruker Corporation
• 31.15. Exact Sciences Corp.

32. Global Adrenal Cancer Diagnostics Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Adrenal Cancer Diagnostics Market

34. Recent Developments In The Adrenal Cancer Diagnostics Market

35. Adrenal Cancer Diagnostics Market High Potential Countries, Segments and Strategies

• 35.1 Adrenal Cancer Diagnostics Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Adrenal Cancer Diagnostics Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Adrenal Cancer Diagnostics Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer